pharma · Schizophrenia · Bipolar I Disorder · LBRX
LB PHARMACEUTICALS
LB PHARMACEUTICALS INC
LB PHARMACEUTICALS patent portfolio — 7 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.
Company details
- Status
- Public
- HQ
- New York, USA
- Founded
- 2015
- Employees
- 36
- Programs
- 3
- Drugs
- 1
- Patents
- 7
LB PHARMACEUTICALS patents
7 pharmaceutical patents indexed for LB PHARMACEUTICALS. 0 expire within 24 months.
LB PHARMACEUTICALS has 7 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 0 expire within 24 months — use filters for patent-cliff planning.
Patent portfolio
-
US 12060327
Psychotropic agents and uses thereof
granted -
US 11713295
Psychotropic agents and uses thereof
granted -
US 11377421
Psychotropic agents and uses thereof
granted -
US 11040943
Psychotropic agents and uses thereof
granted -
US 10689338
Psychotropic agents and uses thereof
granted -
US 10259786
Psychotropic agents and uses thereof
granted -
US 10167256
Psychotrophic agents and uses thereof
granted
Frequently asked questions
How many patents does LB PHARMACEUTICALS have?
7 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).
When do LB PHARMACEUTICALS patents expire?
0 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.